All results
26 results for randomized double blind placebo controlled study erlotinib or placebo patients
-
Clinical Trials
The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) for 52…
-
Clinical Trials
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring…
-
News, Stories & Blog
GAINESVILLE, Fla. — Duchenne muscular dystrophy families, advocates and health care providers celebrated a milestone in March with the U.S. Food and Drug…
-
Clinical Trials
This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and…
-
News, Stories & Blog
For the first time ever, University of Florida Health researchers are evaluating whether or not the combination of heart and bone marrow stem cells can repair…
-
News, Stories & Blog
University of Florida doctors on Wednesday (Oct. 3) treated their first patient enrolled in a new study designed to test whether injecting stem cells into the…
-
News, Stories & Blog
Marco Pahor, director of the UF Institute on Aging (Photo by Sarah Kiewel) The University of Florida is recruiting men older than 65 to take part in a large…
-
Clinical Trials
This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community…
-
Clinical Trials
This is a phase III study of efficacy and safety of secukinumab versus placebo, in combination with glucocorticoid taper regimen, in patients with giant cell…
-
Clinical Trials
A multi-center, placebo-controlled, double blind, 2:1 randomized control clinical trial testing low-dose ATG vs. placebo in subjects with a 2 year 50% risk of…